Abiopharma

New Form SCHEDULE 13G/A - Avalo Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001415889-25-013180 Size: 19 KB

New Form SCHEDULE 13G/A - ELUTIA INC. Filed: 2025-05-15 AccNo: 0001104659-25-049563 Size: 11 KB

New Form 8-K - Solid Biosciences Inc. Filed: 2025-05-15 AccNo: 0000950170-25-072792 Size: 555 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G/A - Vistagen Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001172661-25-002406 Size: 15 KB

New Form NT 10-Q - iSpecimen Inc. Filed: 2025-05-15 AccNo: 0001213900-25-044322 Size: 23 KB

New Form SCHEDULE 13G/A - Pennant Group, Inc. Filed: 2025-05-15 AccNo: 0001999371-25-006240 Size: 25 KB

New Form SCHEDULE 13G - Evolus, Inc. Filed: 2025-05-15 AccNo: 0001104659-25-049561 Size: 10 KB

New Form SCHEDULE 13G - Enhabit, Inc. Filed: 2025-05-15 AccNo: 0001999371-25-006237 Size: 33 KB

New Form SCHEDULE 13G/A - Outlook Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001172661-25-002404 Size: 15 KB

New Form 4 - Tonix Pharmaceuticals Holding Corp. Filed: 2025-05-15 AccNo: 0001999371-25-006236 Size: 5 KB

New Form 4 - ORASURE TECHNOLOGIES INC Filed: 2025-05-15 AccNo: 0001062993-25-009567 Size: 4 KB

New Form 4 - ORASURE TECHNOLOGIES INC Filed: 2025-05-15 AccNo: 0001062993-25-009566 Size: 6 KB

New Form 10-Q - SOBR Safe, Inc. Filed: 2025-05-15 AccNo: 0001477932-25-003832 Size: 699 KB

New Form 8-K - DiaMedica Therapeutics Inc. Filed: 2025-05-15 AccNo: 0001437749-25-017239 Size: 190 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G - Grace Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001104659-25-049554 Size: 11 KB